as on January 28, 2026 at 9:42 pm IST
Day's Low
Day's High
1.42%
Downside
6.17%
Upside
52 Week's Low
52 Week's High
84.00%
Downside
17.83%
Upside
Check Monte Rosa Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.7B
EPS (TTM)
-0.2109
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
69.97
Industry PE ratio
-1.8136016949152542
PEG Ratio
0EBITDA
16.8M
Revenue (TTM)
181.5M
Profit Margin
11.54%
Return On Equity TTM
9.28%
Track how Monte Rosa Therapeutics Inc P/E has moved over time to understand its valuation trends.
Monte Rosa Therapeutics Inc in the last 5 years
Lowest (-19.76x)
September 30, 2025
Industry (-1.81x)
January 28, 2026
Today (69.97x)
January 28, 2026
Highest (149.73x)
December 31, 2025
Today’s Price to Earnings Ratio: 69.97x
Compare market cap, revenue, PE, and other key metrics of Monte Rosa Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.7B | NA | 69.97 | 11.54% | |
| BUY | $47.7B | 129.26% | 1246.03 | 1.36% | |
| BUY | $122.3B | 106.13% | 33.56 | 31.35% | |
| NA | $37.4B | NA | 662.33 | 1.38% | |
| BUY | $80.8B | 52.34% | 18.28 | 32.13% |
The Monte Rosa Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Monte Rosa Therapeutics Inc investment value today
Current value as on today
₹3,81,747
Returns
₹2,81,747
(+281.75%)
Returns from Monte Rosa Therapeutics Inc Stock
₹2,75,773 (+275.77%)
Dollar Returns*
₹5,974 (+5.97%)
Based on 14 analysts
92.86%
Buy
7.14%
Hold
0.00%
Sell
Based on 14 analysts, 92.86% of analysts recommend a 'BUY' rating for Monte Rosa Therapeutics Inc. Average target price of $33.8
Get share price movements and forecasts by analysts on Monte Rosa Therapeutics Inc.
What analysts predicted
35.3%UPSIDE
Target Price
$33.8
Current Price
$21.87
Analyzed by
14 Analysts
Target
$33.80
Monte Rosa Therapeutics Inc target price $33.8, a slight upside of 35.3% compared to current price of $21.87. According to 14 analysts rating.
Investment in Monte Rosa Therapeutics Inc Shares on INDmoney has grown by 281.25% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:281.25% versus previous 30 day period
Search interest for Monte Rosa Therapeutics Inc Stock has increased by 135% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:135% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 15 September
Mon, 08:59 PM
-Monte Rosa announces collaboration with Novartis for novel degraders, receiving $120 million upfront and potential total payments of $5.7 billion.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 6 months, GLUE stock has moved up by 316.2%
Best in 1 Year
![]()
In the last 1 year, GLUE has outperformed top 5 stocks with highest market-cap in its industry
Best in 3 Years
![]()
In the last 3 years, GLUE has outperformed top 5 stocks with highest market-cap in its industry
| Organisation | Monte Rosa Therapeutics Inc |
| Headquarters | 321 Harrison Avenue, Boston, MA, United States, 02118 |
| Industry | Services |
| CEO | Dr. Markus Warmuth M.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Philip Nickson J.D., Ph.D. | Chief Business & Legal Officer |
Mr. Filip Janku M.D., Ph.D. | Chief Medical Officer |
Ms. Jennifer Champoux | Chief Operating Officer |
Dr. Sharon Townson Ph.D. | Chief Scientific Officer |
Mr. Andrew Funderburk | Senior VP and Head of IR & Strategic Finance |
Mr. Magnus Walter DPHIL | Senior Vice President of Drug Discovery |
Mr. Edmund Dunn | Senior VP & Corporate Controller |
Dr. Markus Warmuth M.D. | President, CEO & Director |
Dr. John C. Castle Ph.D. | Chief Data & Information Officer |
Monte Rosa Therapeutics Inc share price today is $21.87 as on . Monte Rosa Therapeutics Inc share today touched a day high of $23.22 and a low of $21.56.
Monte Rosa Therapeutics Inc share touched a 52 week high of $25.77 on and a 52 week low of $3.5 on . Monte Rosa Therapeutics Inc stock price today i.e. is trending at $21.87,which is 15.13% down from its 52 week high and 524.84% up from its 52 week low.
Monte Rosa Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Monte Rosa Therapeutics Inc (GLUE) shares with as little as ₹91.762 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹917.62 in Monte Rosa Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Monte Rosa Therapeutics Inc share’s latest price of $21.87 as on January 28, 2026 at 9:42 pm IST, you will get 0.4572 shares of Monte Rosa Therapeutics Inc. Learn more about
fractional shares .